Preoperative Ultrasound-Guided Peri- Capsular Nerve Group Block on Postoperative Analgesia After Shoulder Arthroscopic Surgery

NCT ID: NCT06790732

Last Updated: 2025-01-24

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 60 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-05-01
• Study Completion Date: 2024-05-01

Brief Summary

This study aimed to evaluate the analgesic efficacy of preoperative ultrasound-guided peri-capsular nerve group block (PENG) on postoperative analgesia after shoulder arthroscopic surgery.

Detailed Description

Postoperative pain control after shoulder surgery is challenging, and poor pain management is invariably reflected in poor outcomes, with longer hospitalization and recovery time. The difficulty in reducing pain due to the complexity of shoulder innervation leads to conducting studies to explore selective axillary nerve blocks with a posterior approach or from the axillae.

The peri-capsular nerve group (PENG) block is a regional anesthetic technique. It can be effectively and safely applied under ultrasound guidance in shoulder surgery cases for postoperative analgesia. It targets only the sensory branches and not the posterior mechanoreceptors; there is a potential motor-sparing effect which is desirable for better physical therapy, and earlier discharge.

Conditions

Preoperative; Ultrasound-Guided; PeriCapsular Nerve Group Block; Postoperative Analgesia; Shoulder Arthroscopic Surgery

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Control Group

Patients received sham PENG block (just 1mL saline).

Group Type: SHAM_COMPARATOR

Saline

Intervention Type: DRUG

Patients received sham PENG block (just 1mL saline).

PeriCapsular Nerve Group Block (PENG) Group

Patients received real PENG block (15 mL of bupivacaine 0.25% +0.2mg/mL dexamethasone).

Group Type: EXPERIMENTAL

Bupivacaine + Dexamethasone

Intervention Type: DRUG

Patients received real PENG block (15 mL of bupivacaine 0.25% +0.2mg/mL dexamethasone).

Interventions

Saline

Patients received sham PENG block (just 1mL saline).

Intervention Type: DRUG

Bupivacaine + Dexamethasone

Patients received real PENG block (15 mL of bupivacaine 0.25% +0.2mg/mL dexamethasone).

Intervention Type: DRUG

Other Intervention Names

PeriCapsular Nerve Group Block (PENG)

Eligibility Criteria

Inclusion Criteria

• Age from 21 to 65 years.
• Both sexes.
• American Society of Anesthesiologists (ASA) physical status I-III.
• Scheduled for unilateral shoulder arthroscopic surgery.

Exclusion Criteria

• Patient refusal.
• Known hypersensitivity to local anesthetics.
• Body mass index> 35 kg /m2.
• Uncooperative or psychiatric patients.
• Infection at the injection site.
• Coagulation disorder.
• Major cardiac, renal, or hepatic diseases.

• Minimum Eligible Age: 21 Years
• Maximum Eligible Age: 65 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Tanta University

OTHER

Sponsor Role: lead

Responsible Party

Kareem Ayman Khattab

Resident of Anesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt.

Responsibility Role: PRINCIPAL_INVESTIGATOR

Locations

Tanta University

Tanta, El-Gharbia, Egypt

Countries

Egypt

Other Identifiers

36264MS117/3/23

Identifier Type: -

Identifier Source: org_study_id